Assure (NASDAQ:IONM) Price Target Lowered to $4.00 at Benchmark

Assure (NASDAQ:IONMGet Rating) had its price target trimmed by Benchmark from $8.00 to $4.00 in a research note issued to investors on Tuesday, The Fly reports.

Separately, Roth Mkm decreased their price target on Assure from $60.00 to $12.00 and set a buy rating on the stock in a research note on Wednesday, April 12th.

Assure Trading Down 1.9 %

Shares of Assure stock opened at $1.04 on Tuesday. Assure has a 52 week low of $0.93 and a 52 week high of $113.00. The business’s fifty day simple moving average is $2.55 and its 200-day simple moving average is $4.02. The company has a quick ratio of 2.58, a current ratio of 2.58 and a debt-to-equity ratio of 7.31.

Insider Buying and Selling

In related news, major shareholder Preston T. Parsons sold 6,600 shares of the stock in a transaction dated Tuesday, April 4th. The stock was sold at an average price of $4.85, for a total transaction of $32,010.00. Following the transaction, the insider now owns 177,525 shares of the company’s stock, valued at approximately $860,996.25. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, major shareholder Preston T. Parsons sold 6,600 shares of the stock in a transaction dated Tuesday, April 4th. The stock was sold at an average price of $4.85, for a total transaction of $32,010.00. Following the transaction, the insider now owns 177,525 shares of the company’s stock, valued at approximately $860,996.25. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, major shareholder Preston T. Parsons sold 7,000 shares of the stock in a transaction dated Friday, March 24th. The stock was sold at an average price of $4.11, for a total value of $28,770.00. Following the transaction, the insider now directly owns 184,125 shares in the company, valued at approximately $756,753.75. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 19,989 shares of company stock valued at $80,976. Corporate insiders own 28.10% of the company’s stock.

Institutional Investors Weigh In On Assure

A hedge fund recently bought a new stake in Assure stock. Empery Asset Management LP purchased a new position in shares of Assure Holdings Corp. (NASDAQ:IONMGet Rating) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 56,264 shares of the company’s stock, valued at approximately $36,000. Empery Asset Management LP owned 0.43% of Assure at the end of the most recent reporting period. Institutional investors and hedge funds own 6.57% of the company’s stock.

About Assure

(Get Rating)

Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services primarily associated with spine and head surgeries. It delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures.

See Also

The Fly logo

Receive News & Ratings for Assure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assure and related companies with MarketBeat.com's FREE daily email newsletter.